‘When it comes to the most despised, Martin Shkreli is up there with Monsanto and the Rockefellers.
Earlier this year, the ‘Pharma Bro’ made headlines when he hiked the price of Daraprim, a decades-old drug used to treat toxoplasmosis, by 5,000%.
After public outcry, Shkreli promised to lower the price of the drug which is heavily relied upon by some AIDS and cancer patients but later reneged on that vow.
Now, the greedy CEO of Turing Pharmaceuticals is poised to put profits over people again. The New York Times reports that Shkreli is likely to increase the price of another decades-old drug used to treat Chagas disease, a parasitic infection that can cause potentially lethal heart problems.’
No comments:
Post a Comment